Feature of Multiple Organs in Ultrasound Investigation for Clinical Management and Prognostic Evaluation of Novel Coronavirus Pneumonia (COVID-19)

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000030017

Enrollment

Unknown

Registered

2020-02-20

Start date

2020-02-17

Completion date

Unknown

Last updated

2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Severe group:None

Non-severe group:None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diagnosis confirmed Novel Coronavirus Pneumonia (COVID-19)

Exclusion criteria

Exclusion criteria: Diagnosis confirmed not coronavirus disease-19.

Design outcomes

Primary

Measure	Time frame
Death;Recovered;Discharged;	—

Secondary

Measure	Time frame
Myocardial Markers;Pericardial effusion;Pleural effusion;Abdominal effusion;	—

Countries

China

Contacts

Public ContactQing Zhou

Renmin Hospital of Wuhan University

qingzhou.wh.edu@hotmail.com+86 13971358226

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026